Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27514-08-5

Post Buying Request

27514-08-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27514-08-5 Usage

Chemical Properties

White solid

Uses

N-(4-Oxocyclohexyl)acetamide is a metabolite of (trans-N-(4-nitroxycyclohexyl)acetamide (CAS 137213-91-3). N-(4-Oxocyclohexyl)acetamide has been used as a reactant in the preparation of 2-Pyrimidinecarbonitrile derivatives as falcipain inhibitors and antiparasitic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 27514-08-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,5,1 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 27514-08:
(7*2)+(6*7)+(5*5)+(4*1)+(3*4)+(2*0)+(1*8)=105
105 % 10 = 5
So 27514-08-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H13NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h7H,2-5H2,1H3,(H,9,10)

27514-08-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H64511)  N-(4-Oxocyclohexyl)acetamide, 98%   

  • 27514-08-5

  • 5g

  • 294.0CNY

  • Detail
  • Alfa Aesar

  • (H64511)  N-(4-Oxocyclohexyl)acetamide, 98%   

  • 27514-08-5

  • 25g

  • 784.0CNY

  • Detail
  • Alfa Aesar

  • (H64511)  N-(4-Oxocyclohexyl)acetamide, 98%   

  • 27514-08-5

  • 100g

  • 2940.0CNY

  • Detail

27514-08-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-Oxocyclohexyl)acetamide

1.2 Other means of identification

Product number -
Other names 4-Acetamidocyclohexanon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27514-08-5 SDS

27514-08-5Synthetic route

trans-N-acetyl-4-hydroxycyclohexylamine
23363-88-4

trans-N-acetyl-4-hydroxycyclohexylamine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
With Jones reagent In acetone at 0 - 30℃;85%
With Jones Reagens In water at 20℃;78%
With sodium dichromate; sulfuric acid In water for 0.333333h;72%
N-((trans)-4-hydroxycyclohexyl)acetamide
27489-60-7

N-((trans)-4-hydroxycyclohexyl)acetamide

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
With chromium(VI) oxide; sulfuric acid at 20℃; for 22h; Oxidation;74%
2-(4-Acetylamino-cyclohexylideneamino)-propionamide
142080-48-6

2-(4-Acetylamino-cyclohexylideneamino)-propionamide

A

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

B

alanine amide
4726-84-5

alanine amide

Conditions
ConditionsYield
With sodium hydroxide In acetonitrile at 20℃; Rate constant; Kinetics; var. temp.;
4-acetaminophenol
103-90-2

4-acetaminophenol

A

N-cyclohexylacetamide
1124-53-4

N-cyclohexylacetamide

B

N-((trans)-4-hydroxycyclohexyl)acetamide
27489-60-7

N-((trans)-4-hydroxycyclohexyl)acetamide

C

cis-(N-4-hydroxycyclohexyl)acetamide
27489-61-8

cis-(N-4-hydroxycyclohexyl)acetamide

D

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
With hydrogen; RuC In ethanol at 119.85℃; under 37503 Torr; Product distribution; Further Variations:; Catalysts; Solvents;
trans-4-hydroxycyclohexylamine
27489-62-9

trans-4-hydroxycyclohexylamine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 97 percent / 1 h / Heating
2: 97 percent / 1M aq. NaOH / 0.5 h / 20 °C
3: 74 percent / CrO3; aq. H2SO4 / 22 h / 20 °C
View Scheme
trans-4-(acetylamino)cyclohexyl acetate
90978-87-3

trans-4-(acetylamino)cyclohexyl acetate

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 97 percent / 1M aq. NaOH / 0.5 h / 20 °C
2: 74 percent / CrO3; aq. H2SO4 / 22 h / 20 °C
View Scheme
4-acetaminophenol
103-90-2

4-acetaminophenol

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: H2 / Raney nickel / ethanol / 3 h / 180 °C / 90500.9 Torr
2: 72 percent / sodium dichromate dihydrate, conc. H2SO4 / H2O / 0.33 h
View Scheme
With borax; hydrogen In diethylene glycol dimethyl ether
With palladium on activated charcoal; hydrogen In aq. acetate buffer at 105℃; under 4500.45 Torr; pH=10;
acetyl chloride
75-36-5

acetyl chloride

4‐aminocyclohexanone

4‐aminocyclohexanone

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
With potassium carbonate In acetonitrile at 20℃; for 18h;
4-acetaminophenol
103-90-2

4-acetaminophenol

A

trans-N-acetyl-4-hydroxycyclohexylamine
23363-88-4

trans-N-acetyl-4-hydroxycyclohexylamine

B

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

Conditions
ConditionsYield
With hydrogen In ethanol at 170℃; under 37503.8 Torr; for 0.333333h; Autoclave;
With hydrogen In ethanol at 170℃; under 37503.8 Torr; for 0.333333h; Autoclave;
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

4-aminocyclohexan-1-one hydrochloride

4-aminocyclohexan-1-one hydrochloride

Conditions
ConditionsYield
With hydrogenchloride for 6h; Heating;100%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

2-bromo-4-acetamidocyclohexanone
687639-03-8

2-bromo-4-acetamidocyclohexanone

Conditions
ConditionsYield
With bromine In chloroform at 22℃; for 0.333333h;100%
With bromine; acetic acid at 60℃; for 1h;
With bromine In water at 45℃;
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

malononitrile
109-77-3

malononitrile

N-(4-(dicyanomethylene)cyclohexyl)acetamide

N-(4-(dicyanomethylene)cyclohexyl)acetamide

Conditions
ConditionsYield
With ammonium acetate; acetic acid In benzene at 130℃; Knoevenagel Condensation; Dean-Stark;97%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

3-amino-N,N'-dihydroxyfurazan-4-carboximidamide

3-amino-N,N'-dihydroxyfurazan-4-carboximidamide

N-(3-(3-aminofurazan-4-yl)-4-hydroxy-1-oxo-2,4-diazaspiro[4,5]decane-2-en-8-yl)acetamide

N-(3-(3-aminofurazan-4-yl)-4-hydroxy-1-oxo-2,4-diazaspiro[4,5]decane-2-en-8-yl)acetamide

Conditions
ConditionsYield
In methanol at 20 - 25℃; for 3h;94%
In methanol at 20℃; for 1h;91%
diethoxyphosphoryl-acetic acid ethyl ester
867-13-0

diethoxyphosphoryl-acetic acid ethyl ester

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

ethyl 2-(trans/cis)-(4-acetamidocyclohexyl)acetate

ethyl 2-(trans/cis)-(4-acetamidocyclohexyl)acetate

Conditions
ConditionsYield
Stage #1: diethoxyphosphoryl-acetic acid ethyl ester With potassium tert-butylate In tetrahydrofuran at 0 - 5℃; for 1h; Wittig-Horner Reaction;
Stage #2: N-(4-oxocyclohexyl)acetamide In tetrahydrofuran at 0 - 20℃; for 2h;
Stage #3: With palladium 10% on activated carbon; hydrogen at 20℃; under 760.051 Torr; for 24h;
92.6%
Stage #1: diethoxyphosphoryl-acetic acid ethyl ester With potassium tert-butylate In tetrahydrofuran at 0 - 5℃; for 1h; Wittig-Horner Reaction;
Stage #2: N-(4-oxocyclohexyl)acetamide In tetrahydrofuran at 0 - 20℃; for 2h; Wittig-Horner Reaction;
Stage #3: With palladium 10% on activated carbon; hydrogen In tetrahydrofuran; ethyl acetate at 20℃; under 760.051 Torr; for 24h;
90%
Stage #1: diethoxyphosphoryl-acetic acid ethyl ester; N-(4-oxocyclohexyl)acetamide With potassium tert-butylate In tetrahydrofuran at 0 - 5℃;
Stage #2: With 5%-palladium/activated carbon; hydrogen In ethyl acetate at 20℃;
benzophenone
119-61-9

benzophenone

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

A

N-(4-benzhydrylidenecyclohexyl)acetamide

N-(4-benzhydrylidenecyclohexyl)acetamide

B

N-(4'-acetylamino-bicyclohexyliden-4-yl)-acetamide

N-(4'-acetylamino-bicyclohexyliden-4-yl)-acetamide

C

1,1,2,2-tetraphenylethylene
632-51-9

1,1,2,2-tetraphenylethylene

Conditions
ConditionsYield
With pyridine; titanium tetrachloride; zinc In tetrahydrofuran Cross McMurry reaction; Heating;A 90.5%
B 2%
C 4%
quinolin-5-yl-hydrazine
15793-79-0

quinolin-5-yl-hydrazine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-[4-(Quinolin-5-yl-hydrazono)-cyclohexyl]-acetamide
102745-87-9

N-[4-(Quinolin-5-yl-hydrazono)-cyclohexyl]-acetamide

Conditions
ConditionsYield
In ethanol for 0.333333h; Heating;89%
methyl (2S)-2-amino-3-phenylpropanoate
2577-90-4

methyl (2S)-2-amino-3-phenylpropanoate

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

methyl N-(4-acetamidophenyl)-L-phenylalaninate

methyl N-(4-acetamidophenyl)-L-phenylalaninate

Conditions
ConditionsYield
With styrene In 1,4-dioxane; water at 140℃; under 3750.38 Torr; for 5h; Catalytic behavior; Flow reactor; enantioselective reaction;88%
4-ethylpiperazine
5308-25-8

4-ethylpiperazine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-(4-(4-ethylpiperazin-1-yl)cyclohexyl)acetamide
1214265-83-4

N-(4-(4-ethylpiperazin-1-yl)cyclohexyl)acetamide

Conditions
ConditionsYield
Stage #1: 4-ethylpiperazine; N-(4-oxocyclohexyl)acetamide With methanesulfonic acid In toluene for 5h; Reflux;
Stage #2: With sodium tetrahydroborate; ethanol In toluene at 15 - 20℃; Inert atmosphere;
87%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-(4-(hydroxyimino)cyclohexyl)acetamide

N-(4-(hydroxyimino)cyclohexyl)acetamide

Conditions
ConditionsYield
With hydroxylamine hydrochloride; sodium acetate In ethanol; water at 100℃;87%
pyrrolidine
123-75-1

pyrrolidine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-(4-Pyrrolidinocyclohex-3-enyl)acetamid
102745-76-6

N-(4-Pyrrolidinocyclohex-3-enyl)acetamid

Conditions
ConditionsYield
In toluene for 3h; Heating;85%
In benzene for 4.5h; Heating;
In toluene for 18h; Molecular sieve; Reflux;
benzyl 2,2-dihydroxy-3-oxobutanoate

benzyl 2,2-dihydroxy-3-oxobutanoate

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

benzyl 2-(5-acetamido-2-oxocyclohexyl)-2-hydroxy-3-oxobutanoate

benzyl 2-(5-acetamido-2-oxocyclohexyl)-2-hydroxy-3-oxobutanoate

Conditions
ConditionsYield
With L-proline In dichloromethane at 20℃; for 32h;85%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

ethylene glycol
107-21-1

ethylene glycol

N-(1,4-Dioxaspiro<4.5>dec-8-yl)acetamid
127686-18-4

N-(1,4-Dioxaspiro<4.5>dec-8-yl)acetamid

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene for 4h; Heating;80%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-acetyl-p-phenylenediamine
122-80-5

N-acetyl-p-phenylenediamine

Conditions
ConditionsYield
With ethene; 5%-palladium/activated carbon; ammonium acetate; potassium carbonate In acetonitrile at 90℃; under 760.051 Torr; for 15h; Reagent/catalyst; Schlenk technique;80%
With styrene; ammonium hydroxide In 1-methyl-pyrrolidin-2-one at 130℃; for 20h; Sealed tube; Inert atmosphere;65%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

4-acetamido-1-ethoxycyclohexene
73625-13-5

4-acetamido-1-ethoxycyclohexene

Conditions
ConditionsYield
With toluene-4-sulfonic acid In ethanol at 25℃; for 16h;78%
2',4'-dihydroxy-4-acetophenone
89-84-9

2',4'-dihydroxy-4-acetophenone

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

C16H19NO4

C16H19NO4

Conditions
ConditionsYield
With pyrrolidine In acetonitrile at 50℃; for 12h;77.1%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

toluene-4-sulfonamide
70-55-3

toluene-4-sulfonamide

N-(4-(4-methylphenylsulfonamido)phenyl)acetamide
27022-64-6

N-(4-(4-methylphenylsulfonamido)phenyl)acetamide

Conditions
ConditionsYield
With 1,10-Phenanthroline; palladium(II) trifluoroacetate; oxygen In toluene at 140℃; for 40h;76%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

2-amino-phenol
95-55-6

2-amino-phenol

N-((5aS*,11aS*,15S*)-6,12-dihydro-5a,11a-butanobenzo[b]benzo[5,6][1,4]oxazino[2,3-e][1,4]oxazin-15-yl)acetamide

N-((5aS*,11aS*,15S*)-6,12-dihydro-5a,11a-butanobenzo[b]benzo[5,6][1,4]oxazino[2,3-e][1,4]oxazin-15-yl)acetamide

Conditions
ConditionsYield
With sulfur; acetic acid; dimethyl sulfoxide at 80℃; for 16h; Inert atmosphere; stereoselective reaction;76%
1-(1-methylethyl)piperazine
4318-42-7

1-(1-methylethyl)piperazine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-(4-(4-i-propylpiperazin-1-yl)cyclohexyl)acetamide
1214265-87-8

N-(4-(4-i-propylpiperazin-1-yl)cyclohexyl)acetamide

Conditions
ConditionsYield
Stage #1: 1-(1-methylethyl)piperazine; N-(4-oxocyclohexyl)acetamide With methanesulfonic acid In toluene for 5h; Reflux;
Stage #2: With sodium tetrahydroborate; ethanol In toluene at 15 - 20℃; Inert atmosphere;
75.6%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

thiourea
17356-08-0

thiourea

2-amino-6-acetylamino-4,5,6,7-tetrahydrobenzothiazole

2-amino-6-acetylamino-4,5,6,7-tetrahydrobenzothiazole

Conditions
ConditionsYield
With bromine In acetic acid at 20 - 30℃; for 5h; Reflux;75%
1-n-propylpiperazine
21867-64-1

1-n-propylpiperazine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-(4-(4-propylpiperazin-1-yl)cyclohexyl)acetamide
1214265-85-6

N-(4-(4-propylpiperazin-1-yl)cyclohexyl)acetamide

Conditions
ConditionsYield
Stage #1: 1-n-propylpiperazine; N-(4-oxocyclohexyl)acetamide With methanesulfonic acid In toluene for 5h; Reflux;
Stage #2: With sodium tetrahydroborate; ethanol In toluene at 15 - 20℃; Inert atmosphere;
73%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

N-<3-<(dimethylamino)methylene>-4-oxocyclohexyl>acetamide

N-<3-<(dimethylamino)methylene>-4-oxocyclohexyl>acetamide

Conditions
ConditionsYield
With triethylamine In benzene Condensation; Heating;72%
With triethylamine In benzene for 5.25h; Heating;57%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

nitrobenzene
98-95-3

nitrobenzene

4-Acetamido-N-phenylaniline
38674-90-7

4-Acetamido-N-phenylaniline

Conditions
ConditionsYield
With palladium diacetate; XPhos In 1-methyl-pyrrolidin-2-one at 150℃; for 24h; Inert atmosphere; Sealed vessel;72%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-(4-(4-methylpiperazin-1-yl)cyclohexyl)acetamide
1214265-81-2

N-(4-(4-methylpiperazin-1-yl)cyclohexyl)acetamide

Conditions
ConditionsYield
Stage #1: 1-methyl-piperazine; N-(4-oxocyclohexyl)acetamide With methanesulfonic acid In toluene for 5h; Reflux;
Stage #2: With sodium tetrahydroborate; ethanol In toluene at 15 - 20℃; Inert atmosphere;
71%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

4R-4-hydroxyproline
51-35-4

4R-4-hydroxyproline

N-(cis-9-oxo-5,6,7,8,8a,9-hexahydro-4aH-pyrrolo[1,2-a]indol-7-yl)acetamide

N-(cis-9-oxo-5,6,7,8,8a,9-hexahydro-4aH-pyrrolo[1,2-a]indol-7-yl)acetamide

Conditions
ConditionsYield
With propionic acid In toluene at 140℃; for 12h; Inert atmosphere; Schlenk technique; stereoselective reaction;70%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

1,2-diamino-benzene
95-54-5

1,2-diamino-benzene

N-(quinoxalino[2,3-a]phenazin-6-yl)acetamide

N-(quinoxalino[2,3-a]phenazin-6-yl)acetamide

Conditions
ConditionsYield
With sulfur; dimethyl sulfoxide; trifluoroacetic acid at 100℃; for 16h; Inert atmosphere;70%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

aniline
62-53-3

aniline

4-Acetamido-N-phenylaniline
38674-90-7

4-Acetamido-N-phenylaniline

Conditions
ConditionsYield
With 1,10-Phenanthroline; oxygen; palladium diacetate In toluene at 135℃; for 37h; Sealed tube;65%
N-(4-oxocyclohexyl)acetamide
27514-08-5

N-(4-oxocyclohexyl)acetamide

N-Cyanoguanidine
127099-85-8, 780722-26-1

N-Cyanoguanidine

(+/-)-N-(2,4-diamino-5,6,7,8-tetrahydro-6-quinazolinyl)acetamide

(+/-)-N-(2,4-diamino-5,6,7,8-tetrahydro-6-quinazolinyl)acetamide

Conditions
ConditionsYield
at 180℃; for 1.5h; Condensation;63%

27514-08-5Relevant articles and documents

Heteroaromatic analogs of benzomorphan. III. Synthesis of 1,2,3,4,5,6 hexahydro 2,6 methano 3 methylpyrido[3,2 d]azocine

Adachi,Nomura,Yamamoto,Mitsuhashi

, p. 2876 - 2880 (1976)

-

Selective hydrogenation of paracetamol to acetamidocyclohexanone with silylated SiO2 supported Pd-based catalysts

Song, Wenjing,Liu, Xiuna,Jiang, Shaoyang,Chen, Zhou,Weng, Weizheng,Rodríguez-Ramos,Yi, Xiaodong,Fang, Weiping

, p. 41572 - 41579 (2016/05/19)

A series of catalysts comprising well-distributed Pd nanoparticles incorporated on silylated SiO2 were fabricated by the wet impregnation method and investigated in the selective hydrogenation of paracetamol to 4-acetamidocyclohexanone. The catalysts calcined at different temperatures were characterized by TG, FT-IR, N2 physisorption, TPR and XPS. The results showed that organic modification led to a catalyst surface composed of stable Si-(CH3)3 species even after calcination at 300 °C. Also, changes occurred in the size and electronic properties of the Pd particles through the different amounts of grafted groups on the SiO2 support. The mode of adsorption of the paracetamol molecule was influenced by the quite bulky organic groups on the support, resulting in a significant improvement in selectivity towards 4-acetamidocyclohexanone and preventing full hydrogenation to some extent. The best result was obtained on the silylated Pd catalyst calcined at 500 °C, with 64.9% selectivity to keto at the paracetamol conversion of 60.5%, while the non-silylated SiO2 supported Pd catalyst gave 4-acetamidocyclohexanone selectivity of 29.1% at 53.8% conversion.

AMINOPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

-

Page/Page column 25, (2010/11/28)

The present invention relates to compounds of formula (I) as defined herein that are melanocortin receptor agonists, to the preparation thereof and to the therapeutic use thereof in the treatment and in the prevention of obesity, diabetes and sexual dysfunctions that can affect both sexes, in the treatment of cardiovascular diseases, and also in anti-inflammatory uses or in the treatment of alcohol dependency.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27514-08-5